Who sold BDX stock in the last quarter?
Apr 14, 2022 · finance.yahoo.com - May 6 at 1:13 PM. BD (BDX) Beats on Q2 Earnings and Revenues, Revises FY22 View. finance.yahoo.com - May 5 at 3:44 PM. Becton, Dickinson Non-GAAP EPS of $3.18 beats by $0.23, revenue of $5.01B beats by $230M; updates FY22 guidance.
What did BDX acquire from CubeX?
Find the latest Becton, Dickinson and Company (BDX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.
Is the deal with $BDXC a good move?
Becton Dickinson & Co. shares rose 0.6% in premarket trades Thursday after the medical products company said its second-quarter profit rose 56% to $431 million, or $1.50 a …
What was the earnings release for Becton Dickinson and Company (BDX)?
Apr 15, 2022 · Becton, Dickinson and's stock was trading at $231.91 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, BDX shares have increased by 7.8% and is now trading at $250.10. View which stocks have been most impacted by COVID-19.
Is BDX a good stock to buy?
Will BDX stock go up?
The 12 analysts offering 12-month price forecasts for Becton Dickinson and Co have a median target of 283.87, with a high estimate of 310.03 and a low estimate of 258.36. The median estimate represents a +11.97% increase from the last price of 253.51.
Is Becton Dickinson stock a buy?
Who owns BDX?
Is BD publicly traded?
Where is Becton Dickinson headquarters?
When was BDX founded?
| Trade name | BD |
|---|---|
| Traded as | NYSE: BDX S&P 500 component |
| Industry | Medical equipment, Consulting |
| Founded | East Rutherford, New Jersey (1897) |
| Founder | Maxwell Becton and Fairleigh S. Dickinson |
Who are Becton Dickinson competitors?
Braun, Cardinal Health, 10X Genomics, Medtronic, Eli Lilly, Baxter International, Zimmer Biomet and Bio-Rad.
Is Becton, Dickinson and a buy right now?
6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Becton, Dickinson and in the last twelve months. There are currently 5 hol...
How has Becton, Dickinson and's stock been impacted by Coronavirus (COVID-19)?
Becton, Dickinson and's stock was trading at $231.91 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World...
When is Becton, Dickinson and's next earnings date?
Becton, Dickinson and is scheduled to release its next quarterly earnings announcement on Wednesday, May 4th 2022. View our earnings forecast for...
How were Becton, Dickinson and's earnings last quarter?
Becton, Dickinson and Company (NYSE:BDX) announced its quarterly earnings results on Thursday, February, 3rd. The medical instruments supplier repo...
How often does Becton, Dickinson and pay dividends? What is the dividend yield for Becton, Dickinson and?
Becton, Dickinson and announced a quarterly dividend on Tuesday, January 25th. Investors of record on Thursday, March 10th will be paid a dividend...
Is Becton, Dickinson and a good dividend stock?
Becton, Dickinson and pays an annual dividend of $3.48 per share and currently has a dividend yield of 1.37%. Becton, Dickinson and has been increa...
How will Becton, Dickinson and's stock buyback program work?
Becton, Dickinson and announced that its board has authorized a share buyback plan on Thursday, November 4th 2021, which permits the company to rep...
What guidance has Becton, Dickinson and issued on next quarter's earnings?
Becton, Dickinson and issued an update on its FY 2022 earnings guidance on Monday, February, 21st. The company provided EPS guidance of $12.800-$13...
What price target have analysts set for BDX?
6 Wall Street analysts have issued twelve-month price objectives for Becton, Dickinson and's stock. Their forecasts range from $260.00 to $310.00....
FOCUS-U.S. COVID-19 tests again in short supply as infections soar, schools reopen
BD (BDX) Veritor At-Home COVID-19 Test Receives EUA From FDA
U.S. companies are scrambling to boost production of coronavirus tests increasingly in short supply as COVID-19 cases soar and schools and employers revive surveillance programs that will require tens of millions of tests, according to industry executives and state health officials.
Here's Why You Should Retain BD (BDX) Stock in Your Portfolio
EUA for BD's (BDX) At-Home COVID-19 test is expected to boost home testing to prevent outbreaks and limit the rise in COVID-19 cases from the Delta variant.
BD Locks FDA Emergency Use Nod For At-Home COVID-19 Antigen Test
Investors continue to be optimistic about BD (BDX) owing to its slew of product launches and regulatory approvals.
BD's Automated Molecular Diagnostics Platform Wins FDA Approval, Initial Test For HPV
The FDA has issued an Emergency Use Authorization (EUA) for Becton Dickinson and Co's (NYSE: BDX) BD Veritor At-Home COVID-19 Test.
Should You Consider Investing in Becton, Dickinson and Company (BDX)?
Becton Dickinson and Co (NYSE: BDX) has received FDA approval for its automated, sample-to-answer, high-throughput BD Cor system along with the BD Onclarity HPV Assay for extended genotyping of human papillomavirus (HPV).
10 Healthcare Dividend Stocks Hedge Funds are Buying
Madison Funds, an investment management firm, published its “Madison Investors Fund” second-quarter 2021 investor letter – a copy of which can be downloaded here. A quarterly portfolio return of 6.82% was recorded by the fund’s Class Y shares for the second quarter of 2021, compared to the S&P 500 Index gains of 8.55% for the same […]
About Becton, Dickinson and
In this article, we will be looking at the 10 healthcare dividend stocks that hedge funds are buying. To skip our detailed analysis of the healthcare sector, you can go directly to see the 5 Healthcare Dividend Stocks Hedge Funds are Buying. While the pandemic has raged on and practically destroyed the foundations of every […]
Becton, Dickinson and (NYSE:BDX) Frequently Asked Questions
Becton, Dickinson & Co. is a medical technology company. The firm engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public.
Recently Viewed Tickers
9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Becton, Dickinson and in the last year. There are currently 5 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Becton, Dickinson and stock.
Becton Dickinson & Co
Visit a quote page and your recently viewed tickers will be displayed here.
What is BDX 2020?
Becton, Dickinson & Co. is a medical technology company. The firm engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public.
Is BDX a 510k?
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued its 2020 Sustainability Report, highlighting significant achievements in environmental, social and governance (ESG) factors that supported the company's 2020 Sustainability Goals – a five year strategy that concluded in 2020. This report marks a milestone for the company's ESG goals, while setting the foundation for new commitments and initiatives that address unmet societal needs, as well a
When will BD report results?
BD ( Becton, Dickinson and Company) ( NYSE: BDX), a leading global medical technology company, today announced it has received 510 (k) clearance from the U.S. Food and Drug Administration (FDA) for the PeritX™ Peritoneal Catheter System for the drainage of symptomatic, recurrent non-malignant ascites. Ascites is a debilitating condition that causes the build-up of fluid in the abdomen.
